global
estim
million
peopl
chronic
infect
hepat
c
viru
hcv
million
person
newli
infect
year
human
immun
system
difficulti
clear
viru
either
acut
chronic
phase
infect
patient
progress
cirrhosi
liver
failur
extens
studi
unravel
import
reliabl
correl
viral
clearanc
togeth
grow
need
diminish
magnitud
hcv
associ
liver
diseas
serv
basi
intens
hcv
vaccin
research
seri
hcv
vaccin
candid
move
clinic
trial
one
peptid
vaccin
consist
panel
mhc
class
class
ii
restrict
epitop
adjuv
polylarginin
administ
healthi
volunt
chronic
hcv
patient
includ
nonrespond
standard
therapi
anoth
therapeut
vaccin
employ
peptid
chosen
individu
abil
induc
strongest
vitro
cellular
respons
vaccin
trial
chronic
hepat
c
patient
receiv
recombin
hcv
envelop
protein
first
clinic
trial
hcv
dna
vaccin
consist
codonoptim
gene
administ
chronic
hepat
c
patient
current
ongo
far
none
peptid
protein
vaccin
abl
induc
signific
improv
health
condit
chronic
hcv
patient
signific
decreas
hcv
rna
load
specif
compar
convent
ifnbas
therapi
vaccin
trial
howev
demonstr
achiev
hcv
rna
declin
vaccin
recipi
correl
induct
strong
ifngamma
tcell
respons
respons
best
recruit
dna
vaccin
either
alon
aid
heterolog
boost
inde
vaccin
chimpanze
show
abil
elicit
effect
immun
heterolog
hcv
strain
use
tcell
orient
hcv
genet
vaccin
stimul
cellular
arm
immun
system
attract
target
hcv
vaccin
nucleocapsid
core
protein
highli
conserv
among
variou
hcv
genotyp
amino
acid
homolog
exceed
core
bind
packag
viral
genom
rna
regul
translat
drive
product
infecti
virus
core
contribut
hcv
persist
also
indirectli
interf
host
cell
transcript
apoptosi
lipid
metabol
develop
immun
respons
extermin
core
express
cell
inhibit
activ
extracellular
core
nonenvelop
particl
contain
hcv
rna
could
highli
benefici
ideal
hcv
core
could
elimin
specif
vaccineinduc
immun
respons
strong
immunogen
anticor
immun
respons
evolv
earli
infect
earli
broad
peripher
intrahepat
tcell
antibodi
respons
corecor
epitop
regist
chimpanze
control
hcv
infect
hcv
chimpanze
becom
chronic
infect
mice
potent
experiment
induc
anticor
immun
respons
confer
partial
protect
challeng
core
express
recombin
vaccinia
viru
howev
despit
high
immunogen
natur
infect
core
perform
well
immunogen
specif
introduc
nake
dna
attempt
enhanc
core
immunogen
target
hcv
core
protein
specif
cellular
compart
coimmun
cytokin
express
plasmid
adjuv
cpg
truncat
core
gene
version
limit
success
primeboost
strategi
use
increas
immun
respons
number
dna
vaccin
immun
regimen
compris
dna
prime
viral
vector
boost
instanc
vaccinia
viru
adenoviru
fowlpox
retroviru
prime
dna
boost
protein
anoth
promis
approach
regimen
studi
hiv
hepat
c
viru
anthrax
mycobacteria
streptococcu
pneumonia
bvdv
dna
vaccin
recombin
protein
vaccin
util
differ
mechan
elicit
antigenspecif
respons
due
product
antigen
transfect
cell
host
dna
vaccin
induc
robust
tcell
respons
critic
develop
tcelldepend
antibodi
respons
dna
immun
also
highli
effect
prime
antigenspecif
memori
b
cell
contrast
recombin
protein
vaccin
gener
effect
elicit
antibodi
respons
cellmedi
immun
respons
may
directli
stimul
antigenspecif
memori
b
cell
differenti
antibodysecret
cell
result
product
high
titer
antigenspecif
antibodi
therefor
dna
prime
plu
protein
boost
complementari
approach
overcom
respect
shortcom
certain
improv
immun
respons
reach
codeliveri
hcv
core
dna
recombin
core
studi
shown
dna
immun
poor
corespecif
immun
respons
consequ
high
level
intracellular
core
express
respons
improv
use
lowexpress
core
gene
singl
core
gene
prime
combin
recombin
core
protein
boost
region
encod
aa
hcv
core
reversetranscrib
amplifi
hcv
isol
genebank
access
use
oligonucleotid
primer
sens
gatccaagcttatgagcacgaatcc
antisens
gatccctcgagtcaagcggaagctgg
contain
recognit
site
hindiii
xhoi
restrict
endonucleas
amplifi
dna
cleav
hindiiixhoi
insert
invitrogen
usa
cleav
hindiiixhoi
result
pcmvcore
region
encod
aa
hcv
core
also
reversetranscrib
amplifi
hcv
isol
use
anoth
set
primer
carri
kozak
consensu
sequenc
sens
agctgctagcgccgccaccatgagcacgaatcct
antisens
gatcgttaactaagcggaagctggatgg
primer
contain
recognit
site
restrict
endonucleas
nhei
xhoi
respect
amplifi
dna
cleav
nheikspai
insert
plasmid
cleav
nheixhoi
result
pcmvcorekozak
region
correspond
hcv
code
sequenc
aa
reversetranscrib
amplifi
hcv
isol
genebank
access
kindli
provid
prof
roggendorf
essen
germani
use
sensegacccaagcttcgtagaccgtgcaccat
antisens
catgctcgagttaggcgtatgctcg
primer
amplifi
dna
cleav
hindiiixhoi
insert
cleav
hindiiixhoi
result
pcmvcoreir
hcv
core
differ
hcv
core
posit
h
versu
r
versu
v
versu
respect
growth
pcmvcore
pcmvcorekozak
pcmvcoreir
accomplish
e
coli
strain
plasmid
dna
extract
purifi
endo
free
plasmid
maxi
kit
qiagen
gmbh
germani
purifi
plasmid
dissolv
phosphat
buffer
salin
pb
use
vitro
express
assay
dna
immun
cell
seed
plate
cellswel
transfect
plasmid
dna
use
lipofectamin
gibcobrl
scotland
exgen
fermenta
lithuania
describ
manufactur
hcv
core
express
analyz
h
post
transfect
cell
lyse
min
buffer
contain
mm
trishcl
ph
mm
edta
mm
pmsf
lysat
clear
min
centrifug
g
resolv
sdspaag
transfer
pvdf
membran
amersham
pharmacia
biotech
ireland
hcv
core
express
detect
immunostain
polyclon
rabbit
anticor
antibodi
secondari
horseradish
peroxidas
hrp
conjug
antirabbit
immunoglobulin
amersham
pharmacia
biotech
ireland
follow
detect
ecl
plu
amersham
pharmacia
biotech
ireland
cell
transfect
either
pcmvcore
pcmvcorekozak
pcmvcoreir
clontech
ca
usa
percent
transfect
evalu
count
number
gfp
express
cell
per
transfect
cell
use
fluoresc
leica
dm
microscop
leica
camera
ag
germani
cell
harvest
h
posttransfect
count
cell
lyse
sd
sampl
buffer
lysat
sampl
contain
ng
recombin
core
aa
correspond
run
simultan
sdspaag
transfer
onto
pvdf
membran
calibr
blot
block
overnight
pbst
nonfat
dri
milk
stain
polyclon
anticor
antibodi
follow
secondari
antirabbit
hrpconjug
antibodi
dakopatt
ab
denmark
signal
detect
use
system
amersham
pharmacia
biotech
ireland
xray
film
scan
process
use
imag
j
softwar
data
present
mean
grey
valu
mgv
core
content
quantifi
plot
mgv
sampl
onto
calibr
curv
prepar
use
recombin
core
aa
core
detect
blot
stripe
accord
ecl
protocol
restain
monoclon
antitubulin
antibodi
sigma
usa
secondari
antimous
hrpconjug
antibodi
dakopatt
ab
denmark
core
content
per
transfect
cell
evalu
account
percent
transfect
normal
tubulin
content
per
well
cell
seed
chamber
slide
nunc
intern
denmark
transfect
h
post
transfect
slide
dri
fix
acet
acid
ethanol
min
rins
thoroughli
distil
water
fix
cell
rehydr
pb
incub
h
antihcv
core
rabbit
polyclon
antibodi
block
buffer
pb
mm
edta
bsa
secondari
antibodi
goat
antirabbit
immunoglobulin
label
tritc
dako
denmark
slide
mount
permafluor
aqueou
mount
medium
immunon
pa
usa
read
use
fluoresc
microscop
peptid
cover
core
amino
acid
control
peptid
ttavpwna
purchas
thermo
electron
gmbh
germani
core
protein
repres
aa
hcv
aa
express
e
coli
purifi
chromatographi
describ
earlier
purifi
protein
dissolv
pb
group
femal
old
mice
stolbovaya
moscow
region
russia
immun
total
pcmvcorekozak
empti
vector
split
four
im
inject
done
week
interv
control
mice
mockimmun
pb
femal
week
old
balbc
mice
anim
breed
centr
institut
microbiolog
virolog
riga
inject
tibiali
anterior
ta
mm
cardiotoxin
latoxan
franc
steril
nacl
five
day
prior
immun
group
mice
immun
singl
dose
either
pcmvcoreir
pcmvcore
pcmvcorekozak
empti
vector
dissolv
pb
appli
intramuscularli
im
cardiotoxintr
ta
control
mice
left
untreat
group
femal
week
old
balbc
mice
pretreat
cardiotoxin
inject
im
pcmvcorekozak
boost
three
week
later
core
aa
pb
prime
boost
subcutan
core
aa
pb
control
anim
left
untreat
mice
bled
retroorbit
sinu
prior
week
immun
week
post
singl
gene
immun
scheme
ii
peptid
correspond
core
aa
coat
onto
maxisorp
plate
nunc
denmark
recombin
core
aa
polysorp
plate
nunc
denmark
coat
done
overnight
mm
carbon
buffer
ph
antigen
concentr
block
pb
contain
bsa
h
serial
dilut
mous
sera
appli
plate
incub
addit
hour
incub
follow
three
wash
pb
contain
afterward
plate
incub
horseradish
peroxidaseconjug
antimous
antibodi
sigma
usa
h
wash
substrat
opd
sigma
usa
ad
color
develop
plate
read
automat
reader
multiscan
sweden
nm
elisa
perform
plate
coat
core
aa
show
similar
result
data
shown
immun
serum
consid
posit
anticor
antibodi
whenev
specif
od
valu
exceed
least
twofold
signal
gener
preimmun
serum
react
corederiv
antigen
immun
serum
react
bsacoat
plate
assay
perform
simultan
tcell
prolifer
test
mice
sacrif
spleen
obtain
two
week
immun
scheme
three
five
week
last
immun
scheme
ii
iii
murin
splenocyt
harvest
use
red
blood
cell
lyse
buffer
sigma
usa
singl
cellsuspens
prepar
rpmi
supplement
mm
lglutamin
fetal
calf
serum
gibco
brl
scotland
cellsml
cell
cultur
ubottom
microcultur
plate
humidifi
chamber
gibco
germani
cell
stimul
perform
peptid
repres
core
aa
recombin
core
aa
aa
dilut
duplic
concanavalin
cona
use
posit
control
cell
grown
h
thymidin
per
well
amersham
pharmacia
biotech
ireland
ad
addit
h
cell
harvest
onto
cellulos
filter
radioact
measur
beta
counter
beckman
usa
result
present
stimul
index
si
calcul
ratio
mean
cpm
obtain
presenc
absenc
stimul
protein
peptid
emptyvector
immun
control
mice
show
si
valu
si
valu
consid
indic
specif
tcell
stimul
detect
cytokin
cell
cultur
fluid
tcell
prolifer
test
collect
h
h
post
onstart
tcell
stimul
detect
cytokin
cell
supernat
perform
use
commerci
elisa
kit
pharmingen
bd
bioscienc
ca
usa
accord
manufactur
instruct
plasmid
construct
encod
core
hcv
isol
without
translat
initi
signal
pcmvcore
kozak
translat
initi
signal
pcmvcorekozak
core
viral
translat
initi
signal
ire
taken
natur
context
deriv
hcv
isol
viral
core
minim
sequenc
differ
posit
three
case
repres
homolog
substitut
express
plasmid
test
vitro
cell
cultur
plasmid
pcmvcore
pcmvcorekozak
use
templat
mrna
transcript
mrna
translat
vitro
rabbit
reticulocyt
lysat
system
mrna
gener
translat
product
approxim
kda
correspond
molecular
mass
unprocess
hcv
core
data
shown
next
coreexpress
vector
use
transfect
seri
mammalian
cell
line
western
blot
transfect
pcmvcore
pcmvcorekozak
pcmvcoreir
use
corespecif
antibodi
demonstr
accumul
protein
expect
molecular
mass
kda
correspond
core
aa
cleav
fulllength
core
cellular
proteas
fig
minim
amount
also
detect
specif
transfect
pcmvcore
pcmvcoreir
fig
overal
level
hcv
core
synthesi
cell
somewhat
higher
cell
fig
cell
line
highest
level
core
express
achiev
pcmvcorekozak
fig
cell
express
core
immunostain
corespecif
antibodi
demonstr
cytoplasm
granular
stain
characterist
process
form
hcv
core
fig
express
capac
vector
quantifi
murin
fibroblast
reproduc
dna
immun
done
mice
core
express
assess
western
blot
sdspaag
resolv
lysat
transfect
core
express
control
plasmid
fig
imag
western
blot
process
use
imagej
softwar
individu
band
repres
arbitrari
unit
mean
grey
valu
mgv
correspond
core
quantiti
establish
use
calibr
curv
built
use
recombin
core
aa
see
addit
file
normal
percent
transfect
protein
content
sampl
plasmid
pcmvcore
translat
initi
signal
provid
lowest
level
core
express
fig
ire
promot
twofold
increas
kozak
sequenc
increas
core
express
ng
protein
produc
per
express
cell
fig
plasmid
direct
highest
level
core
express
select
pilot
experi
defin
strategi
dna
immun
perform
mice
immun
four
time
pcmvcorekozak
corespecif
antibodi
cellular
respons
evalu
specif
respons
regist
inject
data
shown
immun
respons
gener
follow
three
boost
illustr
fig
three
inject
led
increas
corespecif
igg
respons
initi
level
achiev
first
two
plasmid
inject
fig
three
plasmid
inject
gener
better
tcell
prolif
respons
core
corederiv
peptid
two
howev
respons
could
boost
fig
respons
core
also
boostabl
howev
boost
seen
initi
two
pcmvcorekozak
inject
fig
furthermor
repeat
inject
led
signific
decreas
secret
respons
splenocyt
stimul
recombin
core
peptid
repres
core
nterminu
p
fig
data
shown
corespecif
secret
detect
thu
develop
corespecif
immun
respons
occur
within
six
week
onstart
immun
repeat
boost
hcv
core
gene
lead
signific
enhanc
corespecif
immun
next
seri
experi
select
balbc
mice
strain
expect
support
better
respons
stronger
antibodi
product
plasmid
pcmvcore
kozak
given
singl
inject
effect
repeat
intramuscular
dna
boost
substitut
pretreat
inject
site
cardiotoxin
tcell
prolif
respons
antibodi
product
cytokin
secret
monitor
two
five
week
immun
signific
respons
form
corespecif
secret
exceed
background
level
emptyvectorimmun
mice
detect
five
week
singl
administr
hcv
core
gene
immun
gener
corespecif
tcell
respons
low
titer
corespecif
igg
antibodi
respons
hcv
core
alreadi
shown
develop
slowli
mirror
develop
anticor
antibodi
respons
hcv
infect
individu
well
slow
increas
level
anticor
antibodi
observ
day
singl
gene
inject
compar
level
detect
day
data
shown
differ
balbc
mice
respect
corespecif
secret
fig
versu
fig
corespecif
igg
product
p
mann
whitney
utest
fig
versu
fig
addit
file
magnitud
anticor
respons
suggest
increas
hcv
core
gene
dose
either
onetim
larg
dose
inject
repeat
inject
smaller
dose
significantli
enhanc
corespecif
immun
delin
could
influenc
core
express
level
balbc
mice
immun
singl
dose
lowexpress
core
gene
translat
initi
signal
pcmvcore
ire
pcmvcoreir
result
compar
immun
core
gene
regul
kozak
sequenc
pcmvcoreir
fig
tcell
prolif
respons
core
corederiv
peptid
stronger
mice
immun
pcmvcoreir
fig
highest
anticor
igg
respons
rais
mice
immun
pcmvcore
direct
lowest
level
hcv
core
express
fig
fig
significantli
higher
antibodi
respons
induc
pcmvcorekozak
p
immun
respons
pcmvcoreiresimmun
mice
intermedi
fig
tcell
prolif
respons
core
corederiv
peptid
stronger
mice
immun
pcmvcoreir
fig
p
secret
somewhat
higher
mice
immun
highli
express
pcmvcorekozak
dna
immunogen
provid
similar
level
corespecif
secret
fig
aim
see
corespecif
immun
respons
could
enhanc
without
increas
core
gene
dose
instead
use
heterolog
primeboost
immun
regimen
hcv
core
protein
aa
pcmvcorekozak
use
immun
balbc
mice
either
separ
dna
primeprotein
boost
regimen
high
titer
corespecif
antibodi
achiev
heterolog
boost
fig
heterolog
regimen
effect
induc
prolif
respons
si
valu
p
level
mann
whitney
utest
number
posit
tcell
prolifer
test
p
level
fig
potent
corespecif
secret
fig
corespecif
secret
case
low
heterolog
regimen
induc
signific
anticor
antibodi
product
fig
sera
mice
prime
pcmvcorekozak
boost
core
aa
analys
presenc
anticor
antibodi
igg
igm
subclass
result
compar
seroreactv
mice
immun
singl
inject
core
core
express
plasmid
fig
mice
prime
pcmvcorekozak
boost
core
protein
significantli
higher
level
anticor
igg
mice
immun
pcmvcorekozak
p
mannwhitney
utest
pcmvcore
p
immun
pcmvcore
gave
higher
level
igg
immun
pcmvcorekozak
p
group
heterolog
primeboost
regimen
also
increas
level
anticor
although
differ
control
group
reach
level
signific
p
antibodi
subclass
found
low
specif
anticor
igm
observ
mice
immun
recombin
core
aa
p
fig
higher
mice
prime
core
dna
boost
core
protein
p
level
time
coreimmun
mice
anticor
fig
thu
heterolog
core
dna
primecor
protein
boost
regimen
preferenti
induc
anticor
igg
protein
immun
trigger
mostli
lowlevel
anticor
igm
immun
respons
dna
immun
depend
amount
antigen
produc
immunogen
vivo
predetermin
gene
dose
gene
capac
direct
effici
antigen
express
normal
respons
increas
increas
dose
efficaci
gene
express
exampl
see
howev
dna
immunogen
use
encod
structur
compon
viru
also
pathogen
factor
hcv
core
protein
interact
broad
rang
cellular
protein
influenc
numer
host
cell
function
import
hcv
vaccin
design
find
extent
immun
respons
hcv
core
dna
immun
influenc
posit
neg
level
core
express
determin
gene
dose
gene
express
efficaci
ii
first
issu
address
seri
immun
dose
hcv
core
given
singl
split
multipl
inject
other
earlier
observ
repeat
hcv
core
gene
boost
lead
enhanc
corespecif
immun
respons
contrari
corespecif
product
anticor
antibodi
respons
appear
downregul
well
overal
comparison
immun
carri
singl
multipl
core
gene
inject
differ
mous
strain
demonstr
outcom
immun
one
versu
two
four
core
gene
dose
quit
similar
fig
see
also
summari
addit
file
furthermor
antibodi
respons
boost
tcell
prolif
respons
corespecif
secret
could
boost
beyond
level
reach
initi
two
inject
corespecif
secret
even
appear
suppress
thu
corespecif
immun
respons
achiev
singl
dna
immun
repeat
core
gene
administr
may
actual
suppress
corespecif
immun
issu
translat
efficaci
assess
singledos
immun
plasmid
direct
differ
level
hcv
core
express
differ
way
increas
level
gene
express
efficaci
use
strong
promot
optim
speciesspecif
codon
manipul
rna
fold
import
factor
efficaci
translat
initi
capdepend
translat
mammalian
gene
determin
sequenc
flank
aug
initi
codon
high
level
translat
achiev
kozak
sequenc
guanin
posit
adenin
aug
altern
mechan
initi
site
select
eukaryot
cellular
viral
mrna
also
hcv
includ
translat
initi
iress
intern
ribosom
entri
sitesseg
locat
region
viral
genom
hcv
ire
optim
hijack
ribosom
translat
factor
host
translat
hcv
polyprotein
core
tightli
involv
iresmedi
regul
hcv
translat
sever
regulatori
signal
local
core
protein
core
code
sequenc
thu
hcv
genom
incorpor
core
code
sequenc
harmon
evolut
provid
level
core
express
essenti
viru
cap
ire
translat
initi
option
employ
design
core
dna
immunogen
eukaryot
express
vector
construct
encod
core
hcv
without
translat
initi
signal
pcmvcore
core
preced
hcv
isol
ad
pcmvcoreir
core
preced
consensu
kozak
sequenc
pcmvcorekozak
latter
direct
express
core
gene
devoid
translat
initi
signal
core
gene
regul
ire
howev
despit
consider
differ
core
express
capac
kozak
iresregul
dna
immunogen
induc
similar
level
corespecif
secret
fig
secret
somewhat
higher
mice
immun
highli
express
pcmvcorekozak
tcell
prolif
respons
core
corederiv
peptid
stronger
mice
immun
pcmvcoreir
fig
thu
high
core
express
level
promot
better
core
specif
cellular
respons
dnabas
immun
induc
potent
antibodi
respons
includ
viru
neutral
antibodi
howev
signific
antibodi
respons
ever
induc
core
gene
immun
unless
follow
protein
boost
anticor
antibodi
titer
obtain
immun
cap
iresregul
core
gene
also
low
interestingli
howev
significantli
higher
titer
anticor
antibodi
obtain
mice
receiv
least
express
core
gene
devoid
translat
regul
signal
pcmv
core
fig
thu
use
highli
express
hcv
core
dna
promot
effect
corespecif
antibodi
respons
altogeth
point
possibl
advers
effect
highlevel
well
prolong
hcv
core
gene
express
addit
data
support
concept
immun
mice
synthet
truncat
hcv
core
gene
devoid
hcv
core
nucleotidesequ
depend
regulatori
signal
latter
express
hcv
core
five
sixfold
lower
level
viral
fulllength
core
gene
nevertheless
capabl
induc
potent
corespecif
cellular
antibodi
respons
dna
immun
antigen
coexpress
natur
viru
infect
result
inhibit
protein
express
specif
immun
respons
patholog
effect
report
repeat
immun
certain
microbi
gene
exampl
gene
mycobacterium
caus
necrot
bronchointerstiti
pneumonia
bronchiol
healthi
mous
recipi
multifoc
region
cellular
necrosi
lung
appli
therapeut
hcv
core
factor
hcv
pathogen
activ
cellular
viral
promot
induc
er
mitochondri
stress
regul
apoptosi
tumorigenesi
induc
abnorm
lipid
metabol
experiment
system
core
express
lead
develop
divers
patholog
effect
includ
tcell
deplet
liver
steatosi
insulin
resist
hepatocellular
carcinoma
one
notabl
although
controversi
featur
capac
hcv
core
suppress
host
immun
featur
hcv
core
may
explain
better
immun
respons
achiev
singl
immun
vector
provid
compar
low
hcv
core
express
altogeth
point
necess
devis
altern
immun
regimen
would
help
circumv
possibl
advers
effect
hcv
core
mani
approach
pursu
dna
vaccin
combin
heterolog
protein
recombin
viral
boost
consid
promis
principl
strategi
prime
tcell
antigenspecif
upon
repeat
exposur
specif
antigen
induc
rapid
tcell
expans
heterolog
boost
encod
antigen
deliv
differ
formdiffer
vehicl
dna
plasmid
perfectli
fit
prime
sinc
intern
antigen
present
cell
induc
antigen
present
via
mhc
class
class
ii
heterolog
regimen
effect
infect
occur
viral
particl
virusinfect
cell
neither
cellular
antibodi
respons
suffici
steril
protect
viral
clearanc
act
alon
approach
may
help
circumv
neg
effect
intracellular
core
express
inde
heterolog
dnaprimeprotein
boost
strategi
shown
advantag
immun
core
dna
recombin
core
protein
fig
protein
alon
perform
even
wors
singl
dna
inject
fig
heterolog
dnaprimeprotein
boost
regimen
induc
signific
corespecif
antibodi
product
potent
tcell
respons
mainli
may
benefici
sinc
correl
spontan
hcv
clearanc
data
suggest
administr
highli
express
hcv
core
gene
well
repeat
core
gene
inject
may
hamper
corespecif
immun
respons
boost
effect
repeat
core
gene
inject
transient
disappear
subsequ
inject
one
possibl
way
enhanc
corespecif
respons
deliv
limit
intracellular
amount
core
either
give
lower
plasmid
dose
give
vector
low
express
efficaci
addit
option
use
heterolog
dna
primeprotein
boost
regimen
lead
potent
immun
respons
mix
current
test
transient
hcv
core
gene
express
acquisit
antihcv
core
immun
affect
immun
statu
function
immun
system
gene
recipi
author
declar
compet
interest
ek
construct
plasmid
screen
immunogen
ea
experi
express
wrote
draft
manuscript
es
ei
carri
quantif
core
express
ds
np
immunolog
experi
rb
conduct
immunocytochemistri
mi
involv
immunolog
experi
statist
evalu
work
manuscript
tk
pp
give
use
scientif
advic
revis
manuscript
author
read
approv
final
manuscript
